Donate

Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
Julianna Longo

Phone: 206.285.3500

Fax: 206.285.6619

Email: media@path.org

PATH is advancing health equity around the world

June 7, 2024
Medical oxygen in the spotlight: What can be done to improve access for good?
May 30, 2024
A day with co-creators exhibiting inclusive innovation in Kenya
May 29, 2024
Lessons from Malawi's collaborative approach to digital health

Stay informed and make a difference: Subscribe to PATH Insights for a fairer and healthier future

Featured Press Coverage

February 8, 2024
Good intentions, bad outcomes: The dangers of donated medical devices
Devex
April 18, 2024
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The New York Times
February 12, 2024
Could new vaccines end malaria in Africa?
Al Jazeera

Recent Press Coverage

  1. Milken receives $5 million grant to bolster routine immunization in countries facing conflict
    The Milken Institute School of Public Health at George Washington University announced a partnership with PATH, funded by the Bill & Melinda Gates Foundation, to enhance immunization in countries with conflict
    Published: April 2024
  2. Who loses when scientific research is locked behind paywalls?
    An article announcing the Gates Foundation’s refreshed open access and preprint policy highlights the experience of PATH’s Emmanuel Mugisha, who says researchers in low- and middle-income countries face daily barriers as a result of journal paywalls
    Published: March 2024
  3. Five things you need to know about the world’s latest weapon against bacterial meningitis
    The Men5CV (MenFive) pentavalent meningitis vaccine—the result of a 13-year development collaboration between Serum Institute of India and PATH—could help eliminate a leading cause of neurological disease and disability in sub-Saharan Africa.
    Published: March 2024
  4. Kent Campbell, Pivotal Figure in the Fight Against Malaria, Dies at 80
    The New York Times remembers Kent Campbell, the creator and first director of PATH’s Malaria Control and Elimination Partnership in Africa (MACEPA) program. Dr. Campbell is remembered for a legacy of lifesaving work over four decades in public health.
    Published: March 2024
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

957 Item s
957 Item s
    Date
    From
    To
  1. A supply gap of more than 1 billion autodisable syringes could impact COVID-19 immunization efforts in 100 countries
    Global convening of syringe manufacturers and multilateral organizations held to help bolster supply.
    Published: November 2021
    Press Release
  2. PATH congratulates India on nationwide pneumococcal vaccine introduction
    Routine childhood immunization with pneumococcal vaccines is a critical step in India's fight against pneumonia and other pneumococcal diseases.
    Published: November 2021
    Statement
  3. New panel of antibodies available to support the development of affordable pneumococcal vaccines
    New high-quality and affordable serotype-specific monoclonal antibodies (mAbs) now globally available to support vaccine manufacturers in the development of pneumococcal vaccines
    Published: November 2021
    Press Release
  4. New HPV vaccine from Innovax receives WHO prequalification
    This important milestone will provide countries with an additional option for HPV vaccination at an affordable price and will contribute to sustainable supply of HPV vaccine—allowing more girls to be reached with HPV vaccines.
    Published: October 2021
    Announcement
  5. Real-world performance of nOPV2 reinforces strong safety profile
    Experts endorse successful completion of initial use period
    Published: October 2021
    Press Release
Previous
Next